GILD
Gilead Sciences, Inc.
Stock
$149.05−2.23 (−1.47%)Close Sep 30, 2026
Income statement
| Line | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $30.5B | $29.4B | $28.8B | $27.1B | $27.3B | $27.3B | $24.7B | $22.4B | $22.1B | $26.1B | $30.4B | $32.6B | $24.9B | $11.2B | $9.7B | $8.4B | $7.9B | $7.0B | $5.3B | $4.2B |
| Cost of revenue | $6.2B | $6.2B | $6.3B | $6.5B | $5.7B | $6.6B | $4.6B | $4.7B | $4.9B | $4.4B | $4.3B | $4.0B | $3.8B | $2.9B | $2.5B | $2.1B | $1.9B | $1.6B | $1.1B | $769M |
| Gross profit | $24.2B | $23.2B | $22.5B | $20.6B | $21.6B | $20.7B | $20.1B | $17.8B | $17.3B | $21.7B | $26.1B | $28.6B | $21.1B | $8.3B | $7.2B | $6.3B | $6.1B | $5.4B | $4.2B | $3.5B |
| R&D | $6.1B | $5.8B | $5.9B | $5.7B | $5.0B | $4.6B | $4.9B | $9.1B | $5.0B | $3.7B | $5.1B | $3.0B | $2.9B | $2.1B | $1.8B | $1.2B | $1.1B | $940M | $722M | $591M |
| SG&A | $6.5B | $5.8B | $6.1B | $6.1B | $5.7B | $5.2B | $5.2B | $4.4B | $4.1B | $3.9B | $3.4B | $3.4B | $3.0B | $1.7B | $1.5B | $1.2B | $1.0B | $947M | $797M | $706M |
| Other operating expenses | $14.1B | $1.6B | $8.8B | $1.2B | $3.6B | $939M | $6.0B | — | — | — | — | — | — | — | — | — | — | — | $11M | — |
| Operating income | −$2.5B | $10.0B | $1.7B | $7.6B | $7.3B | $9.9B | $4.1B | $4.3B | $8.2B | $14.1B | $17.6B | $22.2B | $15.3B | $4.5B | $4.0B | $3.8B | $4.0B | $3.5B | $2.7B | $2.2B |
| Non-operating income | $542M | −$226M | −$972M | −$746M | −$1.5B | −$1.6B | −$2.4B | $873M | −$401M | −$595M | −$536M | −$534M | −$409M | −$316M | −$398M | −$139M | −$49M | −$27M | −$5.8M | $47M |
| Pretax income | −$2.0B | $9.8B | $690M | $6.9B | $5.8B | $8.3B | $1.7B | $5.2B | $7.8B | $13.5B | $17.1B | $21.7B | $14.9B | $4.2B | $3.6B | $3.7B | $3.9B | $3.5B | $2.7B | $2.2B |
| Taxes | $1.3B | $1.3B | $210M | $1.2B | $1.2B | $2.1B | $1.5B | −$226M | $2.3B | $8.9B | $3.6B | $3.6B | $2.8B | $1.1B | $1.0B | $847M | $1.0B | $866M | $694M | $626M |
| Net income | −$3.2B | $8.5B | $480M | $5.7B | $4.6B | $6.2B | $123M | $5.4B | $5.5B | $4.6B | $13.5B | $18.1B | $12.1B | $3.1B | $2.6B | $2.8B | $2.9B | $2.6B | $2.0B | $1.6B |
| Diluted EPS | −$2.67 | $6.78 | $0.38 | $4.50 | $3.64 | $4.93 | $0.10 | $4.22 | $4.17 | $3.51 | $9.94 | $11.91 | $7.35 | $1.81 | $1.64 | $1.77 | $1.66 | $1.41 | $1.03 | $0.82 |
| Diluted shares | — | 1.26B | 1.26B | 1.26B | 1.26B | 1.26B | 1.26B | 1.28B | 1.31B | 1.32B | 1.36B | 1.52B | 1.65B | 1.70B | 1.58B | 1.58B | 1.75B | 1.87B | 1.92B | 1.93B |
| Revenue growth | — | +2.4% | +6.0% | −0.6% | −0.1% | +10.6% | +10.0% | +1.5% | −15.2% | −14.1% | −6.9% | +31.1% | +122.2% | +15.5% | +15.7% | +5.5% | +13.4% | +31.4% | +26.1% | — |
| Gross margin | 79.6% | 78.8% | 78.3% | 76.0% | 79.3% | 75.8% | 81.5% | 79.2% | 78.1% | 83.3% | 86.0% | 87.7% | 84.8% | 74.5% | 74.5% | 74.7% | 76.5% | 77.2% | 78.9% | 81.8% |
| Operating margin | −8.2% | 34.0% | 5.8% | 28.0% | 26.9% | 36.3% | 16.5% | 19.1% | 37.1% | 54.1% | 58.0% | 68.0% | 61.3% | 40.4% | 41.3% | 45.2% | 49.8% | 50.3% | 50.2% | 51.2% |
| Net margin | −10.6% | 28.9% | 1.7% | 20.9% | 16.8% | 22.8% | 0.5% | 24.0% | 24.7% | 17.7% | 44.4% | 55.5% | 48.6% | 27.5% | 26.7% | 33.4% | 36.5% | 37.6% | 37.1% | 37.5% |
Cost of revenue, other operating expenses, non-operating income and taxes are the differences between the lines reported around them.